Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...
The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.
Fran Drescher says trauma from a home invasion in her 20s contributed to her uterine cancer diagnosis at 42, urging women not ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...
Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall ...
In this retrospective cohort study of a large population in Belgium, researchers aimed to examine endometrial cancer risk in patients with breast cancer who received tamoxifen.
The American Cancer Society reports that five-year cancer survival in the US has reached a historic high of 70% for the first ...
Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) ...
The organization projects more than 2.1 million new cancer cases this year and more than 626,000 deaths from it. The report ...
While rates of cancer diagnosis under age 50 have risen in recent years, this has not translated into increased cancer ...
NP-G2-044 (Prilukae), a novel oral fascin inhibitor, has earned orphan drug designation (ODD) from the FDA for the treatment ...
Frequent use of chemical hair straighteners can increase the risk of uterine cancer. Learn about the dangers and preventive measures from an oncologist.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback